All Work

Jon C. Ogg

MEGA Brands Joins Mattel Toy Empire

MEGA Brands formally will become a part of Mattel. The Canadian toy company's shareholders overwhelmingly approved the merger.

Jon C. Ogg · 12 years ago

Absolute Sticker Shock for New Home Prices

ThinkstockAfter the U.S. Census Bureau released data on new single-family home sales for March Wednesday morning, the big shocker was that new home sales fell by a whopping 14.5% to a seasonally adjusted annual…

Jon C. Ogg · 12 years ago

Verizon Earnings Excitement Muted by AT&T

AT&T did manage to show growth in its first-quarter 2014 earnings, but investors should not at all be surprised about the "sell the news" reaction that has been seen.

Jon C. Ogg · 12 years ago

Lamar to Debut as REIT With Almost 5% Yield

Lamar Advertising has announced that it has received communication from the Internal Revenue Service regarding its plan to convert to a real estate investment trust (REIT).

Jon C. Ogg · 12 years ago

Plug Power Holders Win, and Lose, from Capital Raise

Plug Power is doing something that is good for the company, but at the expense of existing shareholders. The controversialcompany filed to raise capital via the sale of common stock.

Jon C. Ogg · 12 years ago

Why Facebook Has to Blow Away Its Earnings Numbers

Mark Zuckerberg is going to have to deliver strong results to keep Facebook investors happy. If the social media giant does not handily exceed estimates, there may be a real pushback from new investors.

Jon C. Ogg · 12 years ago

Companies Betting on the Next 10 Blockbuster Drugs

24/7 Wall St. wanted to evaluate the prospects for several would-be blockbuster drugs. Some of these have approvals already in hand, while others have pending FDA approval verdicts.

Jon C. Ogg · 12 years ago

Cost Cuts Drive P&G’s Earnings Story

Procter & Gamble managed to turn in a profit gain of less than 2%, due to lower expenses -- a theme that is very common yet again this earnings season. Unfortunately, its revenue was…

Jon C. Ogg · 12 years ago

UBS Top Stocks to Buy Working for Cancer Cures

In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are making major advances in cancer therapeutics. Here is the UBS list of stocks that…

Jon C. Ogg · 12 years ago

An Earnings Tale of Two Biotechs: Gilead vs. Amgen

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) and Amgen Inc. (NASDAQ: AMGN) have both reported earnings. This is a definite difference in how the reports look, and it could throw a wild card report for the…

Jon C. Ogg · 12 years ago

A Sell the News View for AT&T Earnings

Wikimedia CommonsAT&T Inc. (NYSE: T) managed to show something new in its earnings: growth. The telecom giant was a dog for quite some time, but value investors had been snapping up shares after a…

Jon C. Ogg · 12 years ago

Fitch’s More Favorable Rating Outlook on Ford

Fitch Ratings has keyed in on the Issuer Default Ratings for Ford Motor Co. The ratings cover the automaker's underlying credit ratings and that of Ford Motor Credit Co.

Jon C. Ogg · 12 years ago

Xerox Earnings Analysis: A Turnaround Value Trap

Xerox wants to be thought of as a company that has migrated from a copy machine giant to an imaging and storage provider. Unfortunately, the company's earnings fell in the first quarter.

Jon C. Ogg · 12 years ago